lung cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. 18 years old and above; 2. Pathologically confirmed NSCLC; 3. Staging: Ib-III; 4. Received neoadjuvant chemotherapy combined with immunotherapy, regardless of whether radical surgery was performed.
Exclusion criteria
Exclusion criteria: 1. Previously received immunotherapy; 2. No CT from our hospital within 30 days before neoadjuvant chemotherapy combined with immunotherapy; 3. Tumor lesions are not measurable; 4. Poor quality of CT images that cannot be used to extract features; 5. Tumor puncture performed before CT (which will affect the characteristics of CT images); 6. Driver gene mutations in EGFR and ALK genes.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Postoperative pathological response (pathology mostly relieved); | — |
Secondary
| Measure | Time frame |
|---|---|
| Response Evaluation Criteria in Solid Tumours; | — |
Countries
China
Contacts
The Second Xiangya Hospital of Central South University